Half Dose Pegfilgrastim for Patients With Breast Cancer During Chemotherapy: A Case-series.

Mako IkedaYuki KataokaTomoe TajiHirofumi SuwaHideko Nakagoshi

Published in: Anticancer research (2023)

In patients who experienced adverse events due to markedly elevated neutrophil counts with pegfilgrastim, reducing the dose of pegfilgrastim by half may reduce adverse events.

Keyphrases

chemotherapy induced
locally advanced
peripheral blood
radiation therapy
rectal cancer